PBC Landscape - Clinical Trials, Revenue Forecasts

Half The Pipeline From APAC Firms

Primary biliary cholangitis or cirrhosis, PBC, is a lesser-known cousin of MASH but a silent killer, nevertheless. Scrip studies data from Citeline’s Pharmaprojects and separately Evaluate Pharma to reveal a promising pipeline and drug revenue forecasts, with APAC firms accounting for half the pipeline of drugs

Human Liver Model

More from Clinical Trials

More from Rare Diseases